Literature DB >> 7081389

Pathologic and virologic study of fatal Lassa fever in man.

D H Walker, J B McCormick, K M Johnson, P A Webb, G Komba-Kono, L H Elliott, J J Gardner.   

Abstract

Postmortem examination of 21 virologically documented cases of Lassa fever, including 6 complete autopsies, was performed as part of a field study of community-acquired Lassa fever in Sierra Leone. The most consistently observed lesions were hepatocellular, adrenal, and splenic necrosis and adrenal cytoplasmic inclusions. Neither these lesions, nor other milder and less constantly observed lesions such as myocarditis, renal tubular injury, and interstitial pneumonia, appeared severe enough to explain the cause of death in Lassa fever. The central nervous system (CNS) contained no specific lesions. Viral titrations demonstrated high viral content in liver, lung, spleen, kidney, heart, placenta, and mammary gland. Clinical laboratory data included elevation of hepatic enzymes, creatine phosphokinase (CPK), and blood urea nitrogen (BUN). Because of the paucity of pathologic lesions in spite of widely disseminated viral infection, further investigation of humoral inflammatory mechanisms is indicated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081389      PMCID: PMC1916239     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Fatal acute meningoencephalitis due to lymphocytic choriomeningitis virus.

Authors:  R L Warkel; C F Rinaldi; W H Bancroft; R D Cardiff; G E Holmes; R E Wilsnack
Journal:  Neurology       Date:  1973-02       Impact factor: 9.910

2.  Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings.

Authors:  J D Frame; J M Baldwin; D J Gocke; J M Troup
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

3.  [Histopathological diagnosis of hepatitis due to Lassa virus].

Authors:  H Sarrat; R Camain; J Baum; Y Robin
Journal:  Bull Soc Pathol Exot Filiales       Date:  1972 Sep-Oct

4.  Pathology of 12 fatal cases of Argentine hemorrhagic fever.

Authors:  B Elsner; E Schwarz; O G Mando; J Maiztegui; A Vilches
Journal:  Am J Trop Med Hyg       Date:  1973-03       Impact factor: 2.345

5.  The pathology of Lassa fever.

Authors:  G M Edington; H A White
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

6.  Immunofluorescence study of the carrier state and mechanism of vertical transmission in lymphocytic choriomeningitis virus infection in mice.

Authors:  C A Mims
Journal:  J Pathol Bacteriol       Date:  1966-04

7.  Lassa fever, a new virus disease of man from West Africa. IV. Electron microscopy of Vero cell cultures infected with Lassa virus.

Authors:  R W Speir; O Wood; H Liebhaber; S M Buckley
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

8.  Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus.

Authors:  S M Buckley; J Casals
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

9.  Arenoviruses: proposed name for a newly defined virus group.

Authors:  W P Rowe; F A Murphy; G H Bergold; J Casals; J Hotchin; K M Johnson; F Lehmann-Grube; C A Mims; E Traub; P A Webb
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

10.  Bolivian hemorrhagic fever. A pathologic description.

Authors:  P L Child; R B MacKenzie; L R Valverde; K M Johnson
Journal:  Arch Pathol       Date:  1967-05
View more
  78 in total

1.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

Authors:  O Lenz; J ter Meulen; H D Klenk; N G Seidah; W Garten
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan.

Authors:  Stefan Kunz; Jillian M Rojek; Mar Perez; Christina F Spiropoulou; Michael B A Oldstone
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Luis Martínez-Sobrido; Elina I Zúñiga; Debralee Rosario; Adolfo García-Sastre; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Viral protein determinants of Lassa virus entry and release from polarized epithelial cells.

Authors:  Katrin Schlie; Anna Maisa; Fabian Freiberg; Allison Groseth; Thomas Strecker; Wolfgang Garten
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

5.  Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression.

Authors:  Kathryn M Hastie; Christopher R Kimberlin; Michelle A Zandonatti; Ian J MacRae; Erica Ollmann Saphire
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

6.  Pathological and virological features of arenavirus disease in guinea pigs. Comparison of two Pichinde virus strains.

Authors:  J F Aronson; N K Herzog; T R Jerrells
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 7.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

8.  Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.

Authors:  Lauren M Smith; Lisa E Hensley; Thomas W Geisbert; Joshua Johnson; Andrea Stossel; Anna Honko; Judy Y Yen; Joan Geisbert; Jason Paragas; Elizabeth Fritz; Gene Olinger; Howard A Young; Kathleen H Rubins; Christopher L Karp
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

9.  LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration.

Authors:  I S Lukashevich; J D Rodas; I I Tikhonov; J C Zapata; Y Yang; M Djavani; M S Salvato
Journal:  Arch Virol       Date:  2004-08-30       Impact factor: 2.574

10.  Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination.

Authors:  Anura Rambukkana; Stefan Kunz; Jenny Min; Kevin P Campbell; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.